225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

MLA

Sathekge, Mike, et al. “225Ac-PSMA-617 in Chemotherapy-Naive Patients with Advanced Prostate Cancer: A Pilot Study.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 46, no. 1, Jan. 2019, pp. 129–38. EBSCOhost, https://doi.org/10.1007/s00259-018-4167-0.

APA

Sathekge, M., Reyneke, F., Lawal, I., Lengana, T., Davis, C., Mahapane, J., Corbett, C., Vorster, M., Morgenstern, A., Bruchertseifer, F., & Knoesen, O. (2019). 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. European Journal of Nuclear Medicine & Molecular Imaging, 46(1), 129–138. https://doi.org/10.1007/s00259-018-4167-0

Chicago

Sathekge, Mike, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, et al. 2019. “225Ac-PSMA-617 in Chemotherapy-Naive Patients with Advanced Prostate Cancer: A Pilot Study.” European Journal of Nuclear Medicine & Molecular Imaging 46 (1): 129–38. doi:10.1007/s00259-018-4167-0.